Exkivity (mobocertinib) - Takeda
ORIC-114 - ORIC Pharma, Voronoi
tuxobertinib (BDTX-189) - Black Diamond Therap
CLN-081 - Cullinan Oncology
https://www.abstractsonline.com/pp8/#!/10517/presentation/15015
 
Jason E. Long, Soochan Kim, Ha Yeong Kim, Dong Guk Shin, Dong Hyun Park, Robert Warne, Akash Das, Ganapati Hegde, Padmini Narayanan, Lidia Sambucetti, Brenda Chan, Xi Chen, Jae H. Chang, Paul Gibbons, Jessica Sun, Matthew Panuwat, Lori S. Friedman, Melissa R. Junttila
 
Mar 9, 2022
 
Prev Next